Cephalon’s 2006 Marketing Focus: Sparlon For ADHD, Nuvigil For Narcolepsy
Executive Summary
Cephalon will position its attention deficit hyperactivity disorder therapy Sparlon (modafinil) as a "non-traditional" stimulant for inattentive patients with mild-to-moderate hyperactivity
You may also be interested in...
Sparlon Is In Strattera Stratum With Regard To Efficacy, Committee Says
Efficacy of Cephalon's attention deficit/hyperactivity disorder drug Sparlon should be considered to be in the range of Lilly's Strattera, FDA's Psychopharmacologic Drugs Advisory Committee said March 23
Sparlon Is In Strattera Stratum With Regard To Efficacy, Committee Says
Efficacy of Cephalon's attention deficit/hyperactivity disorder drug Sparlon should be considered to be in the range of Lilly's Strattera, FDA's Psychopharmacologic Drugs Advisory Committee said March 23
Sparlon Skin Reaction Safety Study Is Unlikely To Erase Need For Black Box
Labeling for Sparlon for attention deficit/hyperactivity disorder will likely carry a black box warning for severe dermatological reactions even if Cephalon conducts an additional safety study to obtain approval